Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 10/30/2025 | 12.25 M | $230.99 M | 10.30% | 9.65% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 10.75 M | $202.63 M | 0.00% | 8.46% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 10.48 M | $197.51 M | -9.17% | 8.25% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 9.87 M | $186.13 M | 0.00% | 7.78% |
| BLACKROCK, INC. | 11/12/2025 | 8.57 M | $161.62 M | 0.48% | 6.75% |
| VANGUARD GROUP INC | 11/07/2025 | 7.15 M | $134.70 M | 1.38% | 5.63% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 5.30 M | $99.88 M | 5.84% | 4.17% |
| STATE STREET CORP | 11/14/2025 | 4.64 M | $87.49 M | 2.53% | 3.65% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2025 | 4.43 M | $83.49 M | 6.58% | 3.49% |
| MORGAN STANLEY | 11/14/2025 | 4.28 M | $80.61 M | -0.88% | 3.37% |
| UBS GROUP AG | 11/13/2025 | 2.95 M | $55.58 M | 0.36% | 2.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.61 M | $49.14 M | 0.93% | 2.05% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 2.40 M | $45.18 M | 5.92% | 1.89% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 2.31 M | $43.56 M | -15.43% | 1.82% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2025 | 2.12 M | $39.97 M | 0.00% | 1.67% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.12 M | $39.94 M | -2.05% | 1.67% |
| PERPETUAL LTD | 10/10/2025 | 2.02 M | $38.16 M | 7,534.26% | 1.59% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 1.99 M | $37.57 M | -0.42% | 1.57% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.80 M | $34.02 M | -4.51% | 1.42% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 1.66 M | $31.34 M | -3.59% | 1.31% |
| NUVEEN, LLC | 11/12/2025 | 1.37 M | $25.83 M | 79.00% | 1.08% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 1.17 M | $22.09 M | -14.97% | 0.92% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.10 M | $20.68 M | 1.02% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 999.43 K | $18.84 M | 3.56% | 0.79% |
| NORTHERN TRUST CORP | 11/14/2025 | 940.20 K | $17.72 M | 1.24% | 0.74% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 889.29 K | $16.76 M | -26.05% | 0.70% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 833.49 K | $15.71 M | 100.00% | 0.66% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 814.57 K | $15.35 M | 41.05% | 0.64% |
| CANDRIAM S.C.A. | 11/06/2025 | 778.04 K | $14.67 M | -1.57% | 0.61% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 775.00 K | $14.61 M | -22.50% | 0.61% |
| FEDERATED HERMES, INC. | 11/03/2025 | 759.57 K | $14.32 M | 3.01% | 0.60% |
| ABRDN PLC | 11/07/2025 | 675.03 K | $12.72 M | 0.00% | 0.53% |
| JUPITER ASSET MANAGEMENT LTD | 11/10/2025 | 659.33 K | $12.43 M | 59.75% | 0.52% |
| FISHMAN JAY A LTD/MI | 11/05/2025 | 565.65 K | $10.66 M | 100.00% | 0.45% |
| TEJARA CAPITAL LTD | 11/04/2025 | 520.50 K | $9.81 M | -40.40% | 0.41% |
| MYDA ADVISORS LLC | 11/13/2025 | 470.00 K | $8.86 M | 27.03% | 0.37% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 441.32 K | $8.32 M | 17.61% | 0.35% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 411.89 K | $7.76 M | 100.27% | 0.32% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 377.53 K | $7.12 M | 2.75% | 0.30% |
| JANE STREET GROUP, LLC | 11/14/2025 | 360.77 K | $6.80 M | 183.80% | 0.28% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 360.46 K | $6.79 M | -60.96% | 0.28% |
| J. GOLDMAN & CO LP | 11/14/2025 | 353.64 K | $6.67 M | -58.89% | 0.28% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 350.49 K | $6.61 M | 2,306.85% | 0.28% |
| BARCLAYS PLC | 11/12/2025 | 325.97 K | $6.14 M | -17.28% | 0.26% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 318.00 K | $5.99 M | -22.33% | 0.25% |
| WOODLINE PARTNERS LP | 11/14/2025 | 314.62 K | $5.93 M | 53.09% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 310.62 K | $5.86 M | 1.76% | 0.24% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 305.97 K | $5.77 M | -11.18% | 0.24% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2025 | 279.62 K | $5.27 M | -27.56% | 0.22% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 244.02 K | $4.60 M | -39.71% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcutis Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 279 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 12.25 M
Rubric Capital Management LP: 10.75 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 10.48 M
Frazier Life Sciences Management, L.P.: 9.87 M
BlackRock, Inc.: 8.57 M
VANGUARD GROUP INC: 7.15 M
99.04% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 137.16 M shares in the last 24 months. This purchase volume represents approximately $2.73 B in transactions.